Journal
PHARMACOTHERAPY
Volume 40, Issue 9, Pages 936-951Publisher
WILEY
DOI: 10.1002/phar.2447
Keywords
Stenotrophomonas maltophilia; Achromobacter; Burkholderia; Alcaligenes; Elizabethkingia; Chryseobacterium; cefiderocol
Categories
Ask authors/readers for more resources
Stenotrophomonas maltophilia,Burkholderia cepaciacomplex,Elizabethkingiaspp.,Chryseobacteriumspp.,Achromobacterspp., andAlcaligenesspp. are less-common non-lactose-fermenting bacteria that have emerged as important opportunistic pathogens. Patients at the highest risk for these infections include the immunocompromised, those with cystic fibrosis, and the critically ill. These opportunistic pathogens are frequently drug resistant through the expression of beta-lactamases, multidrug efflux pumps, aminoglycoside-modifying enzymes, and target site alterations discussed in detail throughout this review. As a result, treatment is extremely challenging. For each pathogen, this review will examine the epidemiology, mechanisms of resistance, andin vitroandin vivodata including that for novel beta-lactam/beta-lactamase inhibitors and cefiderocol. Treatment recommendations are provided based on the available literature.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available